# Contrast Nephropathy in Type 2 Diabetes

> **NCT03470454** · — · COMPLETED · sponsor: **Fayoum University** · enrollment: 40 (actual)

## Conditions studied

- Kidney Function Affection Upon Exposure to Radiocontrast
- Diabetes
- Microalbuminuria

## Interventions

- **DRUG:** Linagliptin Oral Tablet

## Key facts

- **NCT ID:** NCT03470454
- **Lead sponsor:** Fayoum University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2018-09-30
- **Final completion:** 2018-11-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03470454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03470454, "Contrast Nephropathy in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03470454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*